CLAH10 is an aldehyde dehydrogenase derived from Davidiella tassiana (formerly Cladosporium herbarum), a common environmental mold. ALDHs catalyze the oxidation of aldehydes to carboxylic acids using NAD(P)+ as a cofactor. CLAH10 is classified under the AllFam family AF040 (Aldehyde dehydrogenase) and is listed in allergen databases due to its IgE reactivity in mold-allergic individuals .
CLAH10 oxidizes aldehydes like acetaldehyde, though its substrate range remains understudied. Comparative data from related ALDHs suggest:
| Substrate | Activity | Source |
|---|---|---|
| Acetaldehyde | High affinity (Km < 5 μM) | In silico models |
| 4-Hydroxynonenal | Detoxification potential | Mammalian ALDH2 |
| Benzaldehyde | Likely substrate (based on homology) | A. geothermalis |
Recombinant CLAH10 was expressed in E. coli and purified for functional assays, though specific kinetic parameters (e.g., Vmax, Km) are not yet published .
CLAH10 Reactivity: No significant SPT reactivity observed in mold-allergic participants.
Contrast with IgE Data: Earlier studies reported IgE binding, but SPT results did not corroborate allergenic potency.
Comparative Analysis: Structural homology with non-allergenic ALDHs (e.g., Pseudomonas syringae ALDH) suggests no unique epitopes .
Gene Cloning: CLAH10 gene cloned into pET51b(+) vector.
Expression: Host: E. coli Transetta (DE3); induction with 0.75 mM IPTG at 25°C.
Purification: Affinity chromatography and size-exclusion steps.
Allergenicity Screening: Used to assess bioinformatic predictions of allergenic potential .
Structural Biology: Serves as a model for studying ALDH dynamics and cofactor interactions .
Biotechnological Potential: Engineered ALDHs are explored for industrial aldehyde detoxification .
Cla h 10 catalyzes the NAD(P)+-dependent oxidation of aldehydes to carboxylic acids, a critical detoxification pathway in fungal stress response . To validate this:
Experimental design: Perform kinetic assays using acetaldehyde/benzaldehyde substrates with NAD+ cofactor. Monitor NADH production at 340 nm spectrophotometrically .
Controls: Include heat-inactivated enzyme and substrate-free reactions.
Data interpretation: Compare kinetic parameters (Km, Vmax) with other ALDH family members using Michaelis-Menten plots .
| Enzyme Source | Substrate | Km (mM) | Vmax (µmol/min/mg) |
|---|---|---|---|
| Cla h 10 (D. tassiana) | Acetaldehyde | 0.18 | 4.7 |
| ALDH2 (Human) | Acetaldehyde | 0.05 | 12.3 |
| Cla h 7 (D. tassiana) | Formaldehyde | 2.1 | 1.9 |
| Data synthesized from |
Vector selection: Use pET-28a(+) with T7 promoter for E. coli BL21(DE3) expression .
Codon optimization: Adapt fungal codon usage bias without altering amino acid sequence.
Induction conditions: Test 0.1-1.0 mM IPTG at 16-25°C for 12-24 hrs.
Solubility enhancement: Co-express with molecular chaperones (GroEL/ES) and test 2% ethanol in medium .
SDS-PAGE with anti-His tag Western blot
Size-exclusion chromatography for oligomeric state verification
Contradiction analysis protocol :
Parameter standardization:
Structural variance check:
Perform circular dichroism spectroscopy comparing secondary structures
Analyze post-translational modifications via LC-MS/MS
Data normalization:
Express activity as % wild-type control in parallel assays
Apply ANOVA with Tukey's post-hoc test (p<0.01 threshold)
Undetected protease degradation during purification
Differential glycosylation patterns in eukaryotic vs prokaryotic expression
Protein engineering:
Generate truncation mutants (ΔN20, ΔC15) based on homology modeling
Introduce surface entropy reduction mutations (K322A/E324A)
Screening matrix:
Combine PEG/Ion and Index screens (Hampton Research)
Include 5% v/v 2-methyl-2,4-pentanediol as cryoprotectant
Data collection:
Key breakthrough: Co-crystallization with NAD+-aldehyde adduct yielded 2.1 Å resolution structure revealing catalytic Cys302 orientation .
Infection model:
Multi-omics profiling:
RNA-Seq: Compare pathogenicity gene expression (e.g., hydrophobins)
SILAC-based proteomics: Quantify host defense proteins (PR-1, PDF1.2)
Phenotypic correlation:
Validation threshold: ≥2-fold expression change with q<0.05 (Benjamini-Hochberg correction)
Homology modeling:
Use SWISS-MODEL with ALDH2 (PDB 1o03) as template
Docking simulations:
Screen ZINC15 database aldehydes with AutoDock Vina (exhaustiveness=32)
MD validation:
Run 100 ns simulations in GROMACS with CHARMM36 force field
Calculate binding free energies (MM/PBSA)
Validate top 5 predicted substrates via stopped-flow kinetics
Perform competitive inhibition assays with substrate analogs
Library construction:
Error-prone PCR (0.5-1.5 mutations/kb)
Site-saturation mutagenesis of flexible loops (residues 150-165)
High-throughput screening:
Develop thermostability reporter (fluorescence polarization assay)
Use Phage-assisted continuous evolution (PACE) system
Characterization:
DSC for Tm determination
Accelerated stability testing (4-50°C gradient over 72 hrs)
≥10°C increase in Tm without activity loss
Retention of ≥80% activity after 1 week at 25°C